Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the transition from psoriasis to psoriatic arthritis: the role of targeted therapy.

EULAR rheumatology open·2026
Same author

Body mass index and achievement of minimal disease activity in psoriatic arthritis across different classes of advanced therapy.

Rheumatology (Oxford, England)·2026
Same author

Variable Selection for Illness-Death Processes Under Dual Observation Schemes.

Statistics in medicine·2026
Same author

Two-phase designs for biomarker studies when disease processes are under intermittent observation.

Biometrics·2026
Same author

Repair of radiographic joint damage in psoriatic arthritis: a cohort study.

Rheumatology (Oxford, England)·2026
Same author

An Overview and Recent Developments in the Analysis of Multistate Processes.

Statistics in medicine·2026
Same journal

Transition in Pediatric and Adolescent Hypogonadal Girls: Gynecological Aspects, Estrogen Replacement Therapy, and Contraception.

Endocrine development·2018
Same journal

Transition of Care from Childhood to Adulthood: Congenital Hypogonadotropic Hypogonadism.

Endocrine development·2018
Same journal

Management of Hypothalamic Obesity during Transition from Childhood to Adulthood.

Endocrine development·2018
Same journal

Fertility Preservation in Endocrine Disorders during Transition for Girls.

Endocrine development·2018
Same journal

Transition of Care from Childhood to Adulthood: Turner Syndrome.

Endocrine development·2018
Same journal

Transitions in Care from Pediatric to Adult Health Care Providers: Ongoing Challenges and Opportunities for Young Persons with Diabetes.

Endocrine development·2018
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Clinical trials: planning and analysis.

Vernon T Farewell, Richard J Cook

    Endocrine Development
    |June 5, 2010
    PubMed
    Summary
    This summary is machine-generated.

    This chapter reviews clinical trial design principles for growth hormone therapies, focusing on sample size, subgroup analyses, and randomization. It also covers outcome measures, multiarmed trials, and interpreting trial results.

    More Related Videos

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
    08:36

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

    Published on: April 19, 2024

    Related Experiment Videos

    Last Updated: Jun 12, 2026

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    04:53

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
    08:36

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

    Published on: April 19, 2024

    Area of Science:

    • Clinical Research Methodology
    • Biostatistics in Clinical Trials
    • Endocrinology Research

    Background:

    • Growth hormone therapies require rigorous clinical trial designs.
    • Understanding fundamental and complex aspects of trial design is crucial for reliable results.

    Purpose of the Study:

    • To re-examine basic principles of clinical research.
    • To explore complex aspects of trial design, specifically for growth hormone therapies.
    • To provide guidance on statistical structures and outcome analysis in clinical trials.

    Main Methods:

    • Review of statistical structures underpinning trial design.
    • Analysis of key design elements: sample size, subgroup analyses, multicenter trials, and randomization.
    • Discussion of outcome-related topics: surrogate responses, longitudinal outcomes, and multiple outcomes.
    • Examination of advanced trial designs: multiarmed, factorial, and non-inferiority trials.

    Main Results:

    • Highlights the importance of statistical considerations like sample size and randomization.
    • Discusses the complexities of analyzing various outcome types, including surrogate and longitudinal data.
    • Explores advanced trial designs and their implications for growth hormone studies.

    Conclusions:

    • Effective clinical trial design is essential for advancing growth hormone therapies.
    • Careful consideration of statistical principles and outcome measures enhances study validity.
    • Understanding complex trial designs aids in interpreting study findings accurately.